Targeting melanoma with front-line therapy does not abrogate Nodal-expressing tumor cells

Targeting melanoma with front-line therapy does not abrogate Nodal-expressing tumor cells

Laboratory Investigation 97,
176 (February 2017). doi:10.1038/labinvest.2016.107

Authors: Mary JC Hendrix, Irawati Kandela, Andrew P Mazar, Elisabeth A Seftor, Richard EB Seftor, Naira V Margaryan, Luigi Strizzi, George F Murphy, Georgina V Long & Richard A Scolyer

Source: Laboratory Investigation - January 29, 2017 Category: Laboratory Medicine Authors: Mary JC Hendrix Irawati Kandela Andrew P Mazar Elisabeth A Seftor Richard EB Seftor Naira V Margaryan Luigi Strizzi George F Murphy Georgina V Long Richard A Scolyer Source Type: research